✦ LIBER ✦

p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from thailand

✍ Scribed by Monica C. Hollstein; Christopher P. Wild; Françoise Bleicher; Sopa Chutimataewin; Curtis C. Harris; Andpetcharin Srivatanakul; Ruggero Montesano

Publisher: John Wiley and Sons
Year: 1993
Tongue: French
Weight: 667 KB
Volume: 53
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910530111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aflatoxin B1 and polycyclic aromatic hyd

Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients

✍ Yu-Jing Zhang; Pavel Rossner Jr.; Yu Chen; Meenakshi Agrawal; Qiao Wang; Lillian 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 213 KB 👁 1 views

## Abstract Elevated aflatoxin B~1~‐albumin adducts (AFB~1~‐Alb) have been associated with an increased risk for HCC development. However, there are no studies in humans, correlating albumin adducts in blood with liver DNA adducts. Forty frozen tumor tissues and 39 paired plasma samples from HCC pa

p53 Mutations and hepatitis B virus: Cof

p53 Mutations and hepatitis B virus: Cofactors in hepatocellular carcinoma

✍ Betty L. Slagle 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

afflicted with both HCV and MC. Both Misiani et a1 and Lunel et be 'Ommended for their the mystery surrounding this fascinating group of patients. cryoglobulinemia patients: a randomized, crossover-controlled trial.

Aflatoxin B1 DNA adducts in smeared tumo

Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma

✍ Chien-Jen Chen; Yu-Jing Zhang; Sheng-Nan Lu; Regina M. Santella 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 700 KB

Aflatoxins are well-known animal hepatocarcinogens, but the association between aflatoxins and human hepatocellular carcinoma remains to be elucidated. A study method consisting of indirect immunofluorescence assay combined with densitometry was developed to quantitate aflatoxin B1 DNA adducts in sm

p21/WAF1, p53 and PCNA expression and p5

p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma

✍ Lan Fang Qin; Irene O. L. Ng; Sheung T. Fan; Matthew Ng 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 443 KB 👁 2 views

The cyclin-dependent kinase inhibitor p21/WAF1 is regulated by p53-dependent and p53-independent pathways. In addition, p21/WAF1 binds with proliferating cell nuclear antigen (PCNA) and inhibits the action of PCNA. To investigate the possible role of p21/WAF1 in human hepatocellular carcinomas (HCCs

p53 gene mutations and 17p allelic delet

p53 gene mutations and 17p allelic deletions in hepatocellular Carcinoma from Japan

✍ Haruhiko Nose; Fumio Imazeki; Masao Ohto; Masao Omata 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

CTNNB1 mutations and β-catenin protein a

CTNNB1 mutations and β-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1

✍ Theodora R. Devereux; Mariana C. Stern; Gordon P. Flake; Mimi C. Yu; Zhen-Quan Z 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

## Abstract β‐Catenin plays a key role in the Wnt signaling pathway, and mutations of __CTNNB1__, the gene that encodes β‐catenin, have been identified in about one‐fourth of human hepatocellular carcinomas from regions of low aflatoxin B1 exposure. In this study 62 hepatocellular carcinomas (HCCs)